Skip to ContentSkip to Navigation
About us Latest news News News articles

New operating technique safe for cancer operations

Fluorescent dye makes tumours easier to see
19 January 2011

Fluorescence imaging, where fluorescent dyes are used in cancer operations, is a new technique that can be used in treating various types of cancer. As the tumour tissue lights up, surgeons are better able to see which tissue still contains cancer cells. This is the result of research conducted by medical researcher Lucy Crane of the University Medical Center Groningen. She will be awarded a PhD on 26 January 2011 by the University of Groningen.

In February 2009, UMCG surgeons used this technique for the first time in the Netherlands on patients with breast cancer. Crane conducted a number of early clinical studies in her research on patients with cervical cancer, vulvar carcinoma and ovarian carcinoma. The fluorescence imaging means that the lymph node or tumour lights up, which enables the surgeon to see exactly what tissue must be removed. A fluorescent chemical is used to this end, which can be administered locally or intravenously using a drip. Such contrast dyes can be specific or non-specific. Non-specific fluorescent dyes do not bind specifically to certain cells or organs and are mainly used to show anatomical structures such as lymphatic vessels and lymph nodes. Tumour-specific dyes bind specifically to tumour cells and can be used to detect whether a tumour has metastatized, or to see whether there is still any tumour tissue left in the excision margins.

Crane’s research shows that the technique can be safely applied in treating cervical cancer, vulvar carcinoma and ovarian carcinoma. Early results confirm that the technique is safe and versatile, although there is room for improvement with regard to user-friendliness and adaptability. These could perhaps be improved with more flexible camera systems or with fluorescent dyes that light up somewhat more during the operation.

The research also showed that at this point there is no generally applicable dye available that targets cancer. The reason is that different types of cancer often have varying tumour-specific characteristics. Every type of cancer needs to be further investigated as to which dye works the best and which tumour characteristic it targets. Crane describes in her research a new scoring system used to determine the optimum tumour-specific dye in order to make the best choice.

Ms. L.M.A. (Lucy) Crane (Groningen, 1983) studied Medicine at the University of Groningen. She conducted her research at the Department of Surgery of the UMCG, in close cooperation with the Department of Gynaecology of the Technische Universität München. Her thesis is entitled ‘Intraoperative fluorescence imaging in cancer’. Crane will receive a PhD in Medical Sciences and was supervised by Prof. T. Wiggers and Prof. A.G.J. van der Zee.

Last modified:09 July 2020 2.05 p.m.
View this page in: Nederlands

More news

  • 23 February 2023

    Vici grants for four researchers

    The Dutch Research Council (NWO) has awarded Vici grants, worth €1.5 million each, to four UG/UMCG researchers. Prof. Marleen Kamperman, Prof. Lisa Herzog, Prof. Ming Cao and Prof. Floris Foijer can use this money to develop an innovative line of...

  • 14 February 2023

    Lift to the inclusive workplace

    There is plenty of work, and yet people with a disability are still often sidelined. One plus one is two, or so you’d think: this is the perfect time to help this group of workers find a job. The intention is there, also within the University, but...

  • 26 January 2023

    Comprehensive medical PhD dissertation presents predictors of inflammatory bowel disease

    A PhD dissertation consisting of more than 1100 pages and covering a total of 31 chapters. UMCG PhD-candidate Arno Bourgonje (26) probably wrote the most voluminous medical PhD dissertation ever published in the Netherlands.

    Under the supervision...